FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Actavis Gelnique Recall

Gelnique (oxybutynin chloride) Gel 10%, 100 mg in 1 g sachet, for topical use only

Actavis · Salt Lake City, UT

Risk level
Class III
Reported by FDA
Mar 5, 2014
Recall ID
D-1088-2014
Check your lot numberHow we source this data

Summary

Actavis recalled Gelnique starting Feb 7, 2014. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1088-2014 on Mar 5, 2014. Reason: Subpotent Drug: Drug potency was compromised during shipment. Status: Terminated.

Why it was recalled

Subpotent Drug: Drug potency was compromised during shipment.

Product description

Gelnique (oxybutynin chloride) Gel 10%, 100 mg in 1 g sachet, for topical use only. Physician sample in clamshell container with seven heat-sealed sachets. Rx Only. Watson Pharmaceuticals Inc, Corona, CA, 92890. NDC: 52544-084-77.

Lot numbers, UPCs & expiration codes

Lot #: 514656; Expiry: 03/14

Where it was sold

Distributed nationwide to physicians as samples. No military/ govt/ VA or foreign consignees.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1088-2014
Classification
Class III
Status
Terminated
Recall initiated
Feb 7, 2014
FDA report date
Mar 5, 2014
Quantity
38,227 Clamshells
Recall type
Voluntary: Firm initiated
Recalling firm
Actavis

Original FDA data

Every field from FDA enforcement report D-1088-2014, exactly as published.

Show all FDA fields
City
Salt Lake City
State
UT
Status
Terminated
Country
United States
Event ID
67457
Address
575/577/579 Chipeta Way
Code information
Lot #: 514656; Expiry: 03/14
Postal code
84108-1222
Report date
Mar 5, 2014
Product type
Drugs
Recall number
D-1088-2014
Classification
Class III
Recalling firm
Actavis
Product quantity
38,227 Clamshells
Termination date
Sep 5, 2014
Reason for recall
Subpotent Drug: Drug potency was compromised during shipment.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Gelnique (oxybutynin chloride) Gel 10%, 100 mg in 1 g sachet, for topical use only. Physician sample in clamshell container with seven heat-sealed sachets. Rx Only. Watson Pharmaceuticals Inc, Corona, CA, 92890. NDC: 52544-084-77.
Distribution pattern
Distributed nationwide to physicians as samples. No military/ govt/ VA or foreign consignees.
Recall initiation date
Feb 7, 2014
Initial firm notification
Letter
Center classification date
Feb 25, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1088-2014, published Mar 5, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls